# Novo Holdings A/S

Novo Holdings A/S is an Asset Manager based in Singapore, Singapore, Denmark.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Singapore, Singapore, Denmark
- **Region:** Europe
- **Address:** Hellerup, Denmark
- **Founded:** 1999
- **Assets under management:** 108,000 (per firm, 2025)
- **Website:** novoholdings.dk

## About

Novo Holdings A/S is a SEC-registered investment adviser in Singapore, registered since 2020. It is based in Singapore.

## Sectors

- Life Sciences
- Healthcare Services
- ClimateTech
- Industrial Tech
- FinTech
- Enterprise Software
- Digital Health

## Offices

- Boston, United States
- London, United Kingdom
- San Francisco, United States
- Singapore, Singapore
- Shanghai, China

## People

- Kasper Videbæk — Chief Investment Officer, Novo Holdings
- Henrik Gürtler — Senior Partner, Novo Holdings

## Questions

### Who controls Novo Holdings?

Novo Holdings is wholly owned by the Novo Nordisk Foundation, which controls the majority voting rights in Novo Nordisk A/S and Novozymes A/S. The foundation's board appoints the board of Novo Holdings. This structure separates the philanthropic mission of the foundation from the commercial asset management operations.

### What is the investment strategy of Novo Holdings?

The firm allocates capital across private equity, public equities, and venture capital, with a particular focus on life sciences and healthcare. It also invests in climate tech, industrials, and technology. The private equity team makes direct investments and fund commitments, while the public equities team manages listed holdings including the core Novo Nordisk and Novozymes stakes.

### Does Novo Holdings invest in venture capital?

Yes, Novo Holdings has a dedicated venture capital arm that invests in early-stage life sciences and health technology companies. It has a track record of backing European biotech and health startups, often leading or participating in Series A and B rounds.

### What is the relationship between Novo Holdings and the Novo Nordisk Foundation?

The Novo Nordisk Foundation is the sole shareholder of Novo Holdings. The foundation uses the returns generated by Novo Holdings' investment portfolio to fund philanthropic activities, primarily in medical research and health. Novo Holdings manages the foundation's assets, including the controlling stakes in Novo Nordisk and Novozymes.

### How large is Novo Holdings' portfolio?

As of 2025, Novo Holdings reported approximately $108 billion in assets under management (per the firm). This includes both the concentrated holdings in Novo Nordisk and Novozymes as well as a diversified portfolio of private and public investments.

### Where does Novo Holdings invest geographically?

The firm has investment offices in Hellerup (headquarters), Boston, London, San Francisco, Singapore, and Shanghai. Its investment focus is global, with a significant presence in Europe and North America, and growing activity in Asia.

## Related profiles

- [Holt & Co](https://altss.com/profile/holt-and-co)
- [Dynamic Dental Partners Inc.](https://altss.com/profile/dynamic-dental-partners-inc)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/novo-holdings-as

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology